Search Results - "Oguma, Yasuo"
-
1
Outcome of chemoradiotherapy using intensity-modulated radiation therapy for cervical esophageal cancer: a single institute experience
Published in Esophagus : official journal of the Japan Esophageal Society (01-07-2021)“…Background The role of intensity-modulated radiation therapy in the treatment of cervical esophageal cancer remains unclear. The outcome of concurrent…”
Get full text
Journal Article -
2
Factors predictive of the development of hypothyroidism after intensity-modulated radiation therapy for pharyngeal cancer
Published in Acta oto-laryngologica (02-11-2021)“…Hypothyroidism is a common adverse event after radiotherapy for head and neck tumors and the incidence need to be re-evaluated because of using…”
Get full text
Journal Article -
3
Stereotactic body radiation therapy for multiple lung cancers in a patient with six primary cancers: a case report
Published in Journal of medical case reports (11-07-2024)“…Surgery is the standard care for patients with early-stage lung cancer, and stereotactic body radiation therapy is an option for those who are medically…”
Get full text
Journal Article -
4
Investigation into the Optimal Strategy of Radium-223 Therapy for Metastatic Castration-Resistant Prostate Cancer
Published in Radiation (Multidisciplinary Digital Publishing Institute) (01-09-2022)“…The optimal sequence and combination of radium-223 therapy (Ra-223) for castration-resistant prostate cancer with bone metastasis (mCRPC) remain unclear. This…”
Get full text
Journal Article -
5
Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors
Published in Head & neck (01-10-2021)“…Background The present study aimed to evaluate the prognostic factors in human papillomavirus (HPV)‐positive and HPV‐negative oropharyngeal cancer (OPC)…”
Get full text
Journal Article -
6
Gleason Pattern 5 May Be a Prognostic Factor in Radium-223 Treatment
Published in Cancer diagnosis & prognosis (01-07-2024)“…Radium-223 treatment reduces the risk of death in patients with metastatic castration-resistant prostate cancer (CRPC). This study analyzed the prognostic…”
Get full text
Journal Article